ALOT ALOT
Company Profile ↓Company Overview
ALOT (ALOT) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Jan 2026 Revenue of $150.51M (-0.5% YoY); net profit $-2.38M.
- Trailing 12 Months Year-on-year growth — revenue -0.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 5.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 5.14% |
| 1 Year: | -0.51% |
Stock Price Performance
| 1 Year: | +164.38% |
| 6 Months: | +220.42% |
| 3 Months: | +98.83% |
| 1 Month: | +1.09% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)81.81 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- RSI at 82 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | May 2013 | Aug 2013 | Nov 2013 | May 2014 | Aug 2014 | Nov 2014 | May 2015 | Aug 2015 | Oct 2015 | Apr 2016 | Jul 2016 | Oct 2016 | Apr 2017 | Jul 2017 | Oct 2017 | Apr 2018 | Jul 2018 | Oct 2018 | May 2019 | Aug 2019 | Nov 2019 | May 2020 | Aug 2020 | Oct 2020 | May 2021 | Jul 2021 | Oct 2021 | Apr 2022 | Jul 2022 | Oct 2022 | Apr 2023 | Jul 2023 | Oct 2023 | Apr 2024 | Aug 2024 | Nov 2024 | Apr 2025 | Jul 2025 | Oct 2025 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 27.48M | 28.76M | 31.49M | 33.81M | 34.20M | 36.18M | 33.47M | 33.32M | 30.92M | 27.66M | 28.02M | 29.08M | 29.84M | 28.86M | 31.01M | 32.26M | 39.41M | 35.42M | 35.52M | 37.55M | 32.96M | 40.54M | 40.42M | 37.71M | 36.10M | 39.17M | 39.36M |
| Gross Profit | 5.11M | 6.92M | 7.36M | 8.63M | 9.59M | 10.15M | 9.03M | 9.85M | 10.15M | 9.47M | 10.30M | 9.64M | 9.31M | 10.26M | 11.79M | 12.11M | 13.40M | 13.91M | 14.24M | 11.98M | 12.30M | 10.86M | 9.79M | 9.73M | 10.89M | 12.72M | 10.38M | 10.73M | 11.38M | 12.48M | 12.38M | 9.71M | 14.78M | 11.97M | 14.33M | 13.71M | 11.95M | 11.63M | 14.20M | 14.43M |
| Operating Income | -722.00K | 887.00K | 1.18M | 1.70M | 2.16M | 2.58M | 1.45M | 1.83M | 1.86M | 1.55M | 1.75M | 1.83M | 707.00K | 942.00K | 1.63M | 1.26M | 2.17M | 2.36M | 2.47M | 1.16M | 447.00K | 663.00K | 204.00K | 417.00K | 735.00K | 3.45M | 296.00K | 764.00K | 1.24M | 1.35M | 1.46M | -1.20M | 4.62M | 1.35M | 1.06M | 1.26M | 571.00K | -708.00K | 1.29M | 1.56M |
| Net Income | -449.00K | 696.00K | 1.11M | 1.13M | 1.44M | 1.55M | 1.21M | 1.17M | 1.32M | 1.02M | 1.29M | 1.15M | 512.00K | 727.00K | 1.42M | 814.00K | 1.19M | 1.42M | 1.70M | 951.00K | 456.00K | 432.00K | 3.00K | 12.00K | 593.00K | 7.02M | -425.00K | 425.00K | 584.00K | 289.00K | 848.00K | -1.62M | 2.75M | 1.18M | -311.00K | 240.00K | -376.00K | -1.24M | 378.00K | 653.00K |
| Diluted EPS | -0.06 | 0.09 | 0.14 | 0.14 | 0.18 | 0.20 | 0.16 | 0.16 | 0.18 | 0.14 | 0.17 | 0.15 | 0.07 | 0.11 | 0.21 | 0.12 | 0.17 | 0.20 | 0.23 | 0.13 | 0.06 | 0.06 | 0.00 | 0.00 | 0.08 | 0.96 | -0.06 | 0.06 | 0.08 | 0.04 | 0.11 | -0.22 | 0.37 | 0.15 | -0.04 | 0.03 | -0.05 | -0.16 | 0.05 | 0.08 |
| R&D Expense | 1.11M | 1.27M | 1.23M | 1.37M | 1.48M | 1.56M | 1.80M | 1.56M | 1.84M | 1.44M | 1.75M | 1.34M | 1.50M | 1.68M | 2.03M | 1.69M | 2.03M | 2.12M | 2.01M | 1.78M | 2.08M | 1.94M | 1.49M | 1.41M | 1.72M | 1.54M | 1.95M | 1.52M | 1.59M | 1.90M | 1.79M | 1.56M | 1.68M | 1.60M | 1.41M | 1.84M | 1.53M | 1.58M | 1.90M | 1.81M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jan 2011 | Jan 2012 | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 71.02M | 60.72M | 61.22M | 68.59M | 88.35M | 94.66M | 98.45M | 113.40M | 136.66M | 133.45M | 116.03M | 117.48M | 142.53M | 148.09M | 151.28M | 150.51M |
| Gross Profit | 28.67M | 22.07M | 23.73M | 26.98M | 36.98M | 38.16M | 39.49M | 44.00M | 54.00M | 48.76M | 41.36M | 43.74M | 48.16M | 49.51M | 50.66M | 47.63M |
| Operating Income | 2.76M | 328.00K | 2.93M | 1.53M | 7.23M | 5.93M | 6.28M | 5.41M | 8.72M | 2.43M | 2.43M | 4.26M | 5.44M | 8.80M | -8.64M | 1.21M |
| Net Income | 2.06M | 3.13M | 10.77M | 3.21M | 4.66M | 4.53M | 4.23M | 3.29M | 5.73M | 1.76M | 1.28M | 6.43M | 2.66M | 4.69M | -14.49M | -2.38M |
| Diluted EPS | 0.28 | 0.42 | 1.44 | 0.42 | 0.60 | 0.61 | 0.56 | 0.47 | 0.81 | 0.24 | 0.18 | 0.88 | 0.36 | 0.63 | -1.93 | -0.31 |
| R&D Expense | 5.02M | 4.32M | 3.82M | 5.07M | 5.80M | 6.95M | 6.31M | 7.45M | 7.81M | 8.08M | 6.21M | 6.75M | 6.82M | 6.34M | 6.05M | 6.79M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jan 2010 | Jan 2011 | Jan 2012 | Jan 2013 | Jan 2014 | Feb 2014 | Jan 2015 | Jan 2016 | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 65.00M | 67.06M | 79.91M | 77.96M | - | 74.33M | 77.96M | 83.67M | 122.31M | 118.98M | 116.66M | 115.47M | 114.95M | 139.21M | 133.25M | 145.59M | 137.57M |
| Total Equity | - | 54.29M | 55.66M | 63.84M | 66.61M | 66.61M | 63.51M | 67.37M | 70.54M | 63.65M | 69.78M | 71.38M | 74.68M | 81.01M | 84.37M | 90.28M | 75.75M | 76.86M |
| Cash & Equivalents | 14.16M | 7.72M | 11.70M | 31.00M | 8.34M | 8.34M | 7.96M | 10.04M | 18.10M | 10.18M | 7.53M | 4.25M | 11.44M | 5.28M | 3.95M | 4.53M | 5.05M | 4.07M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | 17.65M | 12.87M | 7.71M | 7.11M | 8.15M | 12.04M | 10.05M | 19.04M | 18.30M |
| Total Liabilities | - | 10.71M | 11.40M | 16.08M | 11.35M | - | 10.82M | 10.59M | 13.13M | 58.67M | 49.21M | 45.29M | 40.79M | 33.94M | 54.84M | 42.97M | 69.84M | 60.70M |
| Current Liabilities | - | 7.50M | 8.27M | 13.53M | 9.89M | - | 9.57M | 9.55M | 11.98M | 25.91M | 24.66M | 26.77M | 20.97M | 20.04M | 37.50M | 29.76M | 46.35M | 38.37M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jan 2011 | Jan 2012 | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.35M | 5.47M | 3.86M | -4.46M | 1.49M | - | 6.95M | 3.72M | 5.00M | 3.22M | 15.54M | 1.39M | -2.94M | 12.35M | 4.85M | 11.74M |
| Investing Cash Flow | -5.40M | 430.00K | 18.47M | -17.72M | 5.75M | - | 3.12M | -20.78M | -1.53M | -2.91M | -2.59M | -1.80M | -17.26M | -875.00K | -20.27M | -219.00K |
| Financing Cash Flow | -2.38M | -1.92M | -3.03M | -1.00M | -7.40M | - | -2.00M | 9.06M | -6.11M | -3.74M | -5.14M | -5.56M | 18.75M | -10.97M | 15.38M | -12.86M |
| Capital Expenditure | -2.09M | -1.15M | -849.00K | -1.13M | -2.25M | -3.06M | -1.24M | -2.20M | -2.65M | -2.91M | -2.59M | -1.80M | -229.00K | -875.00K | -1.17M | -332.00K |
| Free Cash Flow | -742.29K | 4.32M | 3.01M | -5.59M | -756.00K | - | 5.71M | 1.52M | 2.36M | 318.00K | 12.96M | -402.00K | -3.17M | 11.48M | 3.68M | 11.41M |
| Share Buybacks | 975.68K | - | 770.00K | - | 6.25M | - | - | 11.24M | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Jan 2011 | Jan 2012 | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 40.4% | 36.3% | 38.8% | 39.3% | 41.9% | 40.3% | 40.1% | 38.8% | 39.5% | 36.5% | 35.6% | 37.2% | 33.8% | 33.4% | 33.5% | 31.6% |
| Operating Margin % | 3.9% | 0.5% | 4.8% | 2.2% | 8.2% | 6.3% | 6.4% | 4.8% | 6.4% | 1.8% | 2.1% | 3.6% | 3.8% | 5.9% | -5.7% | 0.8% |
| Net Margin % | 2.9% | 5.2% | 17.6% | 4.7% | 5.3% | 4.8% | 4.3% | 2.9% | 4.2% | 1.3% | 1.1% | 5.5% | 1.9% | 3.2% | -9.6% | -1.6% |
| ROE % | 3.8% | 5.6% | 16.9% | 4.8% | 7.3% | 6.7% | 6.0% | 5.2% | 8.2% | 2.5% | 1.7% | 7.9% | 3.2% | 5.2% | -19.1% | -3.1% |
| ROCE % | 4.8% | 0.6% | 4.4% | 2.3% | 11.2% | 8.7% | 8.8% | 5.6% | 9.2% | 2.7% | 2.6% | 4.5% | 5.4% | 8.5% | -8.7% | 1.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ALOT
AstroNova (NASDAQ: ALOT) to be taken private at $29 a share in Arcline deal - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQVnNpSDdtbTZkTzFWbnAtNm1uX3BrRERnVndPTFE1cS1kcnk3YUk2Q2VmVnU2OW43OE83Z21EZGM5SDRhVTNFbFNNY2ExTWIwa1VzRFl1VkgzNDV5eFZCMXhGcHo4V1VaNTdkbU9hOEhOaFp4NWVQcHF5dEV6d2Q5MTBlREtjSGlIOGNQck…
‘A lot of panic around the AI investment’: How a chip slump is driving the Nasdaq toward correction - Fortune
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxQWFJ2OENUXzZ4VFZORnpSZ2xBNVFvMTNfWEx4OW9JSGpyU2UxTkZxRG5OeEpXUHlJZ19LdHJhcUJtMXhFWFFIZmR2aEtLYmFIWnJPZDRtUXBMQ0xaaUxiaVRTOTVxM2NNc1BTLVZrM3AyOFdWWUlnQ2MzUDBGSUNIbjlnazk?oc=5" targ…
Lumentum’s stock just got a lot more interesting — and Barclays has turned bullish - MarketWatch
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOT3paMFQ1TUhXblkyXzE1VzZqUjE3NU96MVhQLVBkWjZ0QVJNdXprSFZHNlBCaGVjUk96VUc3Ym1HRThZTlF6SG9lV3loVENkTkJXd185S3p1VEdIR3ljS1dxcXR3LUNjUXM0aFZoNndHc3E4LW5iZTljRjR1a1otU29XakZ1dUF1MWNFOW…
ALOT|AstroNova Inc|Price:28.920|Chg%:-0.030 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBIcUZ4NC0xWkV2RllwOWdITWk3N2RlcE5BZXRqNTNMNklqUnhTclhpRnF6eGNWd0EtUjlZZUNzdENYLWk3LUpEa05SdGd1QTdSLU9MNENzUV9jcEk2S1ZEbUJ1NV9jU0J0OVI5NVJ3?oc=5" target="_blank">ALOT|AstroNova Inc|…
Why tech stock turmoil makes a lot of sense, in one chart - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQMzk2dzVGZUlOODNVM2VWSEZMaWJZazc1dTRQSWdyMEVvT0tiVjBPU1FHZTJVSC1hMUVuOTluaFZtM1hhVldfTXphWU93T0VaeTc1UVI2VlBEemFHWmF5U0lNbF9WUjBEZzc0ekxTTE5kU2lwQ245V013cEdzWUg2MHNXdm1HWk81aFR4NH…
e.l.f. Stock Hasn't Given Investors a Lot to Cheer About Lately. Here's Why That Could Change. - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNY2cxTjlya0dMellBS1RKZ1ZEcEdnZDBrei1pTldrQU9SV3FjRkdjMEhDc0YtZmJvLTJuZENIOF9qcFA3QWp2ckNZMkVaUXBubk1OX0h0dUZTS1kxbjRTblM3Qmp6WlZVRW9aNUpoeW1UUGRiWG11NjBfeTQ2NldIVjV4Y2pXTzJ1amMwOU…
ALOT — Frequently Asked Questions
What is the current share price of ALOT?
As of 2026-08-05 17:25 PDT, ALOT trades at $28.87 on NASDAQ/NYSE. Its 52-week range is $7.01 to $28.95.
What is the P/E ratio of ALOT?
ALOT trades at a trailing price-to-earnings (P/E) ratio of -93.13.
What is the return on equity (ROE) of ALOT?
ALOT has a return on equity (ROE) of -3.09%. Its return on capital employed (ROCE) is 1.22%.
Is ALOT a good stock to buy?
This page provides a data-driven analysis of ALOT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.